mRNA |
BRD-K33514849 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
0.1 |
mRNA |
AR-42 |
GDSC1000 |
pan-cancer |
AAC |
0.048 |
0.1 |
mRNA |
TW 37 |
GDSC1000 |
pan-cancer |
AAC |
-0.053 |
0.1 |
mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.051 |
0.1 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.047 |
0.1 |
mRNA |
MK 1775 |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.1 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.1 |
mRNA |
AT13387 |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.1 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.051 |
0.1 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.1 |